DETECTION AND PREVALENCE OF THE F-VARIANT OF EPSTEIN-BARR-VIRUS IN SOUTHERN CHINA

被引:73
作者
LUNG, ML
LAM, WP
SHAM, J
CHOY, DM
ZONG, YS
GUO, HY
NG, MH
机构
[1] QUEEN MARY HOSP,DEPT RADIOTHERAPY & ONCOL,HONG KONG,HONG KONG
[2] SHANTOU UNIV,COLL MED,DEPT PATHOL & ONCOL,SHANTOU,PEOPLES R CHINA
[3] SUN YAT SEN UNIV MED SCI,DEPT MICROBIOL,GUANGZHOU,PEOPLES R CHINA
关键词
D O I
10.1016/0042-6822(91)90754-Y
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The "f" variant of Epstein-Barr virus (EBV) may have an association with the development and/or maintenance of nasopharyngeal carcinoma (NPC) among Southern Chinese. This variant is detected at a higher frequency among individuals with elevated IgA antibody levels against EBV capsid antigen who have no detectable NPC and in NPC patients as compared to healthy individuals or patients who are in remission for NPC for over 3 years. Conversion or replacement of the f variant by the prototype BamHI F virus usually occurs by 3 to 4 years after radiotherapy. By 5 years post-therapy the majority of people in remission for NPC no longer harbor the f variant in their oropharynx. Eradication of this f variant, however, does not appear essential for maintenance of a disease-free state since several patients harboring this variant were in remission for NPC for up to 21 years. The virus strain detected directly in the nasopharynx is not always identical to that seen in the oropharynx. Dual infection was commonly observed in throat washings of NPC patients although the biopsy from tumors harbored unique strains of EBV. © 1991.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 20 条
[1]   PCR AS A RAPID SCREENING METHOD FOR TRANSGENIC MICE [J].
ABBOTT, C ;
POVEY, S ;
VIVIAN, N ;
LOVELLBADGE, R .
TRENDS IN GENETICS, 1988, 4 (11) :325-325
[2]   RELATIONSHIP BETWEEN EPSTEIN-BARR VIRUS AND UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA - CORRELATED NUCLEIC-ACID HYBRIDIZATION AND HISTOPATHOLOGICAL EXAMINATION [J].
ANDERSSONANVRET, M ;
FORSBY, N ;
KLEIN, G ;
HENLE, W .
INTERNATIONAL JOURNAL OF CANCER, 1977, 20 (04) :486-494
[3]   NO EVIDENCE FOR DIFFERENCES IN THE EPSTEIN-BARR VIRUS GENOME CARRIED IN BURKITT-LYMPHOMA CELLS AND NONMALIGNANT LYMPHOBLASTOID-CELLS FROM THE SAME PATIENTS [J].
BORNKAMM, GW ;
VONKNEBELDOEBERITZ, M ;
LENOIR, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (15) :4930-4934
[4]  
CHANG RS, 1971, JNCI-J NATL CANCER I, V47, P469
[5]   EBNA SIZE POLYMORPHISM CAN BE USED TO TRACE EPSTEIN-BARR-VIRUS SPREAD WITHIN FAMILIES [J].
GRATAMA, JW ;
OOSTERVEER, MAP ;
KLEIN, G ;
ERNBERG, I .
JOURNAL OF VIROLOGY, 1990, 64 (10) :4703-4708
[6]  
HAUSEN HZ, 1970, NATURE, V228, P1056
[7]   EPSTEIN-BARR VIRUS-SPECIFIC IGA SERUM ANTIBODIES AS AN OUTSTANDING FEATURE OF NASOPHARYNGEAL CARCINOMA [J].
HENLE, G ;
HENLE, W .
INTERNATIONAL JOURNAL OF CANCER, 1976, 17 (01) :1-7
[8]  
HO HC, 1978, LANCET, V1, P436
[9]   EPSTEIN-BARR-VIRUS-SPECIFIC IGA AND IGG SERUM ANTIBODIES IN NASOPHARYNGEAL CARCINOMA [J].
HO, HC ;
NG, MH ;
KWAN, HC ;
CHAU, JCW .
BRITISH JOURNAL OF CANCER, 1976, 34 (06) :655-660
[10]   FRAGMENT LENGTH POLYMORPHISMS AMONG INDEPENDENT ISOLATES OF EPSTEIN-BARR VIRUS FROM IMMUNOCOMPROMISED AND NORMAL HOSTS [J].
KATZ, BZ ;
NIEDERMAN, JC ;
OLSON, BA ;
MILLER, G .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (02) :299-308